Brief: Agile Therapeutics- Reaffirmed Its Previously Announced Operating Expense Guidance For Full Year 2020 To Be In Range Of $52 Mln To $56 Mln

Agile Therapeutics

21/09/2020 22:02

Sept 21 (Reuters) - Agile Therapeutics Inc  AGRX.O :
    * AGILE THERAPEUTICS INC - REAFFIRMED ITS PREVIOUSLY
ANNOUNCED
OPERATING EXPENSE GUIDANCE FOR FULL YEAR 2020 TO BE IN RANGE OF
$52 MILLION TO $56 MILLION
    * AGILE THERAPEUTICS INC -  REAFFIRMED ITS PREVIOUSLY
ANNOUNCED
NET REVENUE GUIDANCE FOR Q4 OF 2020 TO BE IN RANGE OF $1 MILLION
TO $2 MILLION
    * AGILE THERAPEUTICS - CASH, CASH EQUIVALENTS AND MARKETABLE
SECURITIES AS OF JUNE 30, 2020 WILL BE SUFFICIENT THROUGH END OF
2021

Source text: https://bit.ly/2EkxozF
Further company coverage:  AGRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))